Varicella-Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine - Levin, M. J.; Oxman, M. N.; J. H. Zhang; Johnson, G. R.; Stanley, H.; Hayward, A. R.; Caulfield, M. J.; Irwin, M. R.; Smith, J. G.; Clair, J.; Chan, I. S. F.; Williams, H.; et al. (The Journal of infectious diseases, 2008)
Keywords: Age Factors; Age groups; Aged; Antibodies; Antibodies, Viral - blood; Applied microbiology; Biological and medical sciences; Double-Blind Method; Female; Fundamental and applied biological sciences. Psychology; Geometric mean; Herpes zoster; Herpes Zoster - immunology; Herpes Zoster - prevention & control; Herpes Zoster - virology; Herpes zoster vaccine; Herpes Zoster Vaccine - blood; Herpes Zoster Vaccine - immunology; Herpes Zoster Vaccine - pharmacokinetics; Herpes Zoster Vaccine - therapeutic use; Herpesvirus 3, Human - immunology; Human viral diseases; Humans; Immunity, Cellular; Immunology; Infectious diseases; Major And Brief Reports; Male; Medical sciences; Microbiology; Miscellaneous; Older adults; Placebos; Vaccination; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, Attenuated - immunology; Vaccines, Attenuated - pharmacokinetics; Vaccines, Attenuated - therapeutic use; Varicella zoster encephalitis; Varicella-zoster virus; Viral diseases; Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye; Virology; Viruses; Human; Varicella zoster virus; Skin disease; Nervous system diseases; Herpes zoster; Immune response; Herpesviridae; Alphaherpesvirinae; Recipient; Vaccine; Infection; Virus; Viral disease; Elderly